Results per Page:
Good News: Dr. Eduardo Méndez receives $2.2M in NIH funding for targeted therapies for head and neck cancers
Celebrating faculty and staff achievements
Good News: GeekWire Award Finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others
Celebrating faculty and staff achievements
Good News at Fred Hutch: Dr. Anne McTiernan named to HHS panel; Dr. Harlan Robins is co-PI on two projects
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
Dr. Lily Selim receives inaugural CTI BioPharma International Postdoctoral Research Fellowship
Pediatric hematologist/oncologist studies new ways to detect and manage early leukemia relapse in children
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
An easy pairing
Fred Hutch’s Harlan Robins develops a new method to match thousands of pairs of key genes needed for cancer immunotherapy
Predicting ovarian cancer by counting tumor-attacking immune cells
Study led by Jason Bielas finds new way to quantify immune cells reliably, quickly and cheaply
Genital herpes-suppressing immune cells identified
Discovery by Fred Hutchinson Cancer Research Center’s Dr. Larry Corey and colleagues has implications for development of vaccine to prevent and treat HSV-2, similar infections
High-throughput sequencing outpaces flow cytometry for earliest detection of cancer relapse
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
Detecting earliest signs of cancer relapse: Study finds high-throughput sequencing outpaces flow cytometry
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
T-cell receptors reveal immune system similarities
Finding may lead to new cancer detection, diagnostic and treatment methods
When it comes to the immune system, we're all more alike than previously thought, study finds
Finding may lead to new ways to detect, diagnose, and treat cancer and other diseases